Global Non-animal Type Hard Capsules Market Insights, Forecast to 2034
The global Non-animal Type Hard Capsules market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
Global Non-animal Type Hard Capsules market is expected to reach to US$ 1053.4 million in 2024, with a positive growth of %, compared with US$ 1005.4 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Non-animal Type Hard Capsules industry is evaluated to reach US$ 1408.4 million in 2029. The CAGR will be 5.0% during 2024 to 2029.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2024, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 223%.
Report Covers
This report presents an overview of global Non-animal Type Hard Capsules market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Non-animal Type Hard Capsules market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Lonza
Catalent
ACG Associated Capsules
Qualicaps (Mitsubishi Chemical)
Bahrain Pharma
JC Biological Technology
CapsCanada
Medicaps
Aenova
Patheon (Banner Pharmacaps)
Roxlor
Sunil Healthcare
Arab-Caps
Jedco International Pharmaceutical
Pharco
ACPL
Hunan Er-Kang Pharmaceutical Co., Ltd
Procaps S.A
Segment by Type
Type I
00E
0E
Segment by Application
Pharmaceutical
Nutraceutical
Cosmetics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Non-animal Type Hard Capsules plant distribution, commercial date of Non-animal Type Hard Capsules, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Non-animal Type Hard Capsules introduction, etc. Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Non-animal Type Hard Capsules
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Non-animal Type Hard Capsules Product Introduction
1.2 Market by Type
1.2.1 Global Non-animal Type Hard Capsules Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 00E
1.2.4 0E
1.3 Market by Application
1.3.1 Global Non-animal Type Hard Capsules Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Nutraceutical
1.3.4 Cosmetics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-animal Type Hard Capsules Sales Estimates and Forecasts 2018-2029
2.2 Global Non-animal Type Hard Capsules Revenue by Region
2.2.1 Global Non-animal Type Hard Capsules Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Non-animal Type Hard Capsules Revenue by Region (2018-2024)
2.2.3 Global Non-animal Type Hard Capsules Revenue by Region (2024-2029)
2.2.4 Global Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2029)
2.3 Global Non-animal Type Hard Capsules Sales Estimates and Forecasts 2018-2029
2.4 Global Non-animal Type Hard Capsules Sales by Region
2.4.1 Global Non-animal Type Hard Capsules Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Non-animal Type Hard Capsules Sales by Region (2018-2024)
2.4.3 Global Non-animal Type Hard Capsules Sales by Region (2024-2029)
2.4.4 Global Non-animal Type Hard Capsules Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Non-animal Type Hard Capsules Sales by Manufacturers
3.1.1 Global Non-animal Type Hard Capsules Sales by Manufacturers (2018-2024)
3.1.2 Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-animal Type Hard Capsules in 2022
3.2 Global Non-animal Type Hard Capsules Revenue by Manufacturers
3.2.1 Global Non-animal Type Hard Capsules Revenue by Manufacturers (2018-2024)
3.2.2 Global Non-animal Type Hard Capsules Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Non-animal Type Hard Capsules Revenue in 2022
3.3 Global Key Players of Non-animal Type Hard Capsules, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Non-animal Type Hard Capsules Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Non-animal Type Hard Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Non-animal Type Hard Capsules, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Non-animal Type Hard Capsules, Product Offered and Application
3.8 Global Key Manufacturers of Non-animal Type Hard Capsules, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-animal Type Hard Capsules Sales by Type
4.1.1 Global Non-animal Type Hard Capsules Historical Sales by Type (2018-2024)
4.1.2 Global Non-animal Type Hard Capsules Forecasted Sales by Type (2024-2029)
4.1.3 Global Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
4.2 Global Non-animal Type Hard Capsules Revenue by Type
4.2.1 Global Non-animal Type Hard Capsules Historical Revenue by Type (2018-2024)
4.2.2 Global Non-animal Type Hard Capsules Forecasted Revenue by Type (2024-2029)
4.2.3 Global Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Non-animal Type Hard Capsules Price by Type
4.3.1 Global Non-animal Type Hard Capsules Price by Type (2018-2024)
4.3.2 Global Non-animal Type Hard Capsules Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Non-animal Type Hard Capsules Sales by Application
5.1.1 Global Non-animal Type Hard Capsules Historical Sales by Application (2018-2024)
5.1.2 Global Non-animal Type Hard Capsules Forecasted Sales by Application (2024-2029)
5.1.3 Global Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
5.2 Global Non-animal Type Hard Capsules Revenue by Application
5.2.1 Global Non-animal Type Hard Capsules Historical Revenue by Application (2018-2024)
5.2.2 Global Non-animal Type Hard Capsules Forecasted Revenue by Application (2024-2029)
5.2.3 Global Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Non-animal Type Hard Capsules Price by Application
5.3.1 Global Non-animal Type Hard Capsules Price by Application (2018-2024)
5.3.2 Global Non-animal Type Hard Capsules Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Non-animal Type Hard Capsules Market Size by Type
6.1.1 US & Canada Non-animal Type Hard Capsules Sales by Type (2018-2029)
6.1.2 US & Canada Non-animal Type Hard Capsules Revenue by Type (2018-2029)
6.2 US & Canada Non-animal Type Hard Capsules Market Size by Application
6.2.1 US & Canada Non-animal Type Hard Capsules Sales by Application (2018-2029)
6.2.2 US & Canada Non-animal Type Hard Capsules Revenue by Application (2018-2029)
6.3 US & Canada Non-animal Type Hard Capsules Market Size by Country
6.3.1 US & Canada Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Non-animal Type Hard Capsules Sales by Country (2018-2029)
6.3.3 US & Canada Non-animal Type Hard Capsules Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Non-animal Type Hard Capsules Market Size by Type
7.1.1 Europe Non-animal Type Hard Capsules Sales by Type (2018-2029)
7.1.2 Europe Non-animal Type Hard Capsules Revenue by Type (2018-2029)
7.2 Europe Non-animal Type Hard Capsules Market Size by Application
7.2.1 Europe Non-animal Type Hard Capsules Sales by Application (2018-2029)
7.2.2 Europe Non-animal Type Hard Capsules Revenue by Application (2018-2029)
7.3 Europe Non-animal Type Hard Capsules Market Size by Country
7.3.1 Europe Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Non-animal Type Hard Capsules Sales by Country (2018-2029)
7.3.3 Europe Non-animal Type Hard Capsules Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Non-animal Type Hard Capsules Market Size
8.1.1 China Non-animal Type Hard Capsules Sales (2018-2029)
8.1.2 China Non-animal Type Hard Capsules Revenue (2018-2029)
8.2 China Non-animal Type Hard Capsules Market Size by Application
8.2.1 China Non-animal Type Hard Capsules Sales by Application (2018-2029)
8.2.2 China Non-animal Type Hard Capsules Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Non-animal Type Hard Capsules Market Size by Type
9.1.1 Asia Non-animal Type Hard Capsules Sales by Type (2018-2029)
9.1.2 Asia Non-animal Type Hard Capsules Revenue by Type (2018-2029)
9.2 Asia Non-animal Type Hard Capsules Market Size by Application
9.2.1 Asia Non-animal Type Hard Capsules Sales by Application (2018-2029)
9.2.2 Asia Non-animal Type Hard Capsules Revenue by Application (2018-2029)
9.3 Asia Non-animal Type Hard Capsules Sales by Region
9.3.1 Asia Non-animal Type Hard Capsules Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Non-animal Type Hard Capsules Revenue by Region (2018-2029)
9.3.3 Asia Non-animal Type Hard Capsules Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Non-animal Type Hard Capsules Market Size by Type
10.1.1 Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Non-animal Type Hard Capsules Market Size by Application
10.2.1 Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Country
10.3.1 Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Overview
11.1.3 Lonza Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Lonza Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Overview
11.2.3 Catalent Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Catalent Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Catalent Recent Developments
11.3 ACG Associated Capsules
11.3.1 ACG Associated Capsules Company Information
11.3.2 ACG Associated Capsules Overview
11.3.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ACG Associated Capsules Recent Developments
11.4 Qualicaps (Mitsubishi Chemical)
11.4.1 Qualicaps (Mitsubishi Chemical) Company Information
11.4.2 Qualicaps (Mitsubishi Chemical) Overview
11.4.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Qualicaps (Mitsubishi Chemical) Recent Developments
11.5 Bahrain Pharma
11.5.1 Bahrain Pharma Company Information
11.5.2 Bahrain Pharma Overview
11.5.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Bahrain Pharma Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bahrain Pharma Recent Developments
11.6 JC Biological Technology
11.6.1 JC Biological Technology Company Information
11.6.2 JC Biological Technology Overview
11.6.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 JC Biological Technology Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 JC Biological Technology Recent Developments
11.7 CapsCanada
11.7.1 CapsCanada Company Information
11.7.2 CapsCanada Overview
11.7.3 CapsCanada Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 CapsCanada Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CapsCanada Recent Developments
11.8 Medicaps
11.8.1 Medicaps Company Information
11.8.2 Medicaps Overview
11.8.3 Medicaps Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Medicaps Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medicaps Recent Developments
11.9 Aenova
11.9.1 Aenova Company Information
11.9.2 Aenova Overview
11.9.3 Aenova Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Aenova Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aenova Recent Developments
11.10 Patheon (Banner Pharmacaps)
11.10.1 Patheon (Banner Pharmacaps) Company Information
11.10.2 Patheon (Banner Pharmacaps) Overview
11.10.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Patheon (Banner Pharmacaps) Recent Developments
11.11 Roxlor
11.11.1 Roxlor Company Information
11.11.2 Roxlor Overview
11.11.3 Roxlor Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Roxlor Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Roxlor Recent Developments
11.12 Sunil Healthcare
11.12.1 Sunil Healthcare Company Information
11.12.2 Sunil Healthcare Overview
11.12.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Sunil Healthcare Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sunil Healthcare Recent Developments
11.13 Arab-Caps
11.13.1 Arab-Caps Company Information
11.13.2 Arab-Caps Overview
11.13.3 Arab-Caps Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Arab-Caps Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Arab-Caps Recent Developments
11.14 Jedco International Pharmaceutical
11.14.1 Jedco International Pharmaceutical Company Information
11.14.2 Jedco International Pharmaceutical Overview
11.14.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jedco International Pharmaceutical Recent Developments
11.15 Pharco
11.15.1 Pharco Company Information
11.15.2 Pharco Overview
11.15.3 Pharco Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Pharco Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pharco Recent Developments
11.16 ACPL
11.16.1 ACPL Company Information
11.16.2 ACPL Overview
11.16.3 ACPL Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 ACPL Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 ACPL Recent Developments
11.17 Hunan Er-Kang Pharmaceutical Co., Ltd
11.17.1 Hunan Er-Kang Pharmaceutical Co., Ltd Company Information
11.17.2 Hunan Er-Kang Pharmaceutical Co., Ltd Overview
11.17.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments
11.18 Procaps S.A
11.18.1 Procaps S.A Company Information
11.18.2 Procaps S.A Overview
11.18.3 Procaps S.A Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Procaps S.A Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Procaps S.A Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-animal Type Hard Capsules Industry Chain Analysis
12.2 Non-animal Type Hard Capsules Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-animal Type Hard Capsules Production Mode & Process
12.4 Non-animal Type Hard Capsules Sales and Marketing
12.4.1 Non-animal Type Hard Capsules Sales Channels
12.4.2 Non-animal Type Hard Capsules Distributors
12.5 Non-animal Type Hard Capsules Customers
13 Market Dynamics
13.1 Non-animal Type Hard Capsules Industry Trends
13.2 Non-animal Type Hard Capsules Market Drivers
13.3 Non-animal Type Hard Capsules Market Challenges
13.4 Non-animal Type Hard Capsules Market Restraints
14 Key Findings in The Global Non-animal Type Hard Capsules Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Non-animal Type Hard Capsules Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Type I
Table 3. Major Manufacturers of 00E
Table 4. Major Manufacturers of 0E
Table 5. Global Non-animal Type Hard Capsules Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Non-animal Type Hard Capsules Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Non-animal Type Hard Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2024)
Table 10. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2024-2029)
Table 11. Global Non-animal Type Hard Capsules Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Non-animal Type Hard Capsules Sales by Region (2018-2024) & (K Units)
Table 13. Global Non-animal Type Hard Capsules Sales by Region (2024-2029) & (K Units)
Table 14. Global Non-animal Type Hard Capsules Sales Market Share by Region (2018-2024)
Table 15. Global Non-animal Type Hard Capsules Sales Market Share by Region (2024-2029)
Table 16. Global Non-animal Type Hard Capsules Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Non-animal Type Hard Capsules Sales Share by Manufacturers (2018-2024)
Table 18. Global Non-animal Type Hard Capsules Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Non-animal Type Hard Capsules, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Non-animal Type Hard Capsules Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Non-animal Type Hard Capsules Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Non-animal Type Hard Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-animal Type Hard Capsules as of 2022)
Table 24. Global Key Manufacturers of Non-animal Type Hard Capsules, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Non-animal Type Hard Capsules, Product Offered and Application
Table 26. Global Key Manufacturers of Non-animal Type Hard Capsules, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Non-animal Type Hard Capsules Sales by Type (2018-2024) & (K Units)
Table 29. Global Non-animal Type Hard Capsules Sales by Type (2024-2029) & (K Units)
Table 30. Global Non-animal Type Hard Capsules Sales Share by Type (2018-2024)
Table 31. Global Non-animal Type Hard Capsules Sales Share by Type (2024-2029)
Table 32. Global Non-animal Type Hard Capsules Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Non-animal Type Hard Capsules Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Non-animal Type Hard Capsules Revenue Share by Type (2018-2024)
Table 35. Global Non-animal Type Hard Capsules Revenue Share by Type (2024-2029)
Table 36. Non-animal Type Hard Capsules Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Non-animal Type Hard Capsules Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Non-animal Type Hard Capsules Sales by Application (2018-2024) & (K Units)
Table 39. Global Non-animal Type Hard Capsules Sales by Application (2024-2029) & (K Units)
Table 40. Global Non-animal Type Hard Capsules Sales Share by Application (2018-2024)
Table 41. Global Non-animal Type Hard Capsules Sales Share by Application (2024-2029)
Table 42. Global Non-animal Type Hard Capsules Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Non-animal Type Hard Capsules Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Non-animal Type Hard Capsules Revenue Share by Application (2018-2024)
Table 45. Global Non-animal Type Hard Capsules Revenue Share by Application (2024-2029)
Table 46. Non-animal Type Hard Capsules Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Non-animal Type Hard Capsules Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Non-animal Type Hard Capsules Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Non-animal Type Hard Capsules Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Non-animal Type Hard Capsules Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Non-animal Type Hard Capsules Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Non-animal Type Hard Capsules Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Non-animal Type Hard Capsules Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Non-animal Type Hard Capsules Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Non-animal Type Hard Capsules Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Non-animal Type Hard Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Non-animal Type Hard Capsules Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 61. Europe Non-animal Type Hard Capsules Sales by Type (2018-2024) & (K Units)
Table 62. Europe Non-animal Type Hard Capsules Sales by Type (2024-2029) & (K Units)
Table 63. Europe Non-animal Type Hard Capsules Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Non-animal Type Hard Capsules Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Non-animal Type Hard Capsules Sales by Application (2018-2024) & (K Units)
Table 66. Europe Non-animal Type Hard Capsules Sales by Application (2024-2029) & (K Units)
Table 67. Europe Non-animal Type Hard Capsules Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Non-animal Type Hard Capsules Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Non-animal Type Hard Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Non-animal Type Hard Capsules Sales by Country (2018-2024) & (K Units)
Table 73. Europe Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 74. China Non-animal Type Hard Capsules Sales by Type (2018-2024) & (K Units)
Table 75. China Non-animal Type Hard Capsules Sales by Type (2024-2029) & (K Units)
Table 76. China Non-animal Type Hard Capsules Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Non-animal Type Hard Capsules Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Non-animal Type Hard Capsules Sales by Application (2018-2024) & (K Units)
Table 79. China Non-animal Type Hard Capsules Sales by Application (2024-2029) & (K Units)
Table 80. China Non-animal Type Hard Capsules Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Non-animal Type Hard Capsules Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Non-animal Type Hard Capsules Sales by Type (2018-2024) & (K Units)
Table 83. Asia Non-animal Type Hard Capsules Sales by Type (2024-2029) & (K Units)
Table 84. Asia Non-animal Type Hard Capsules Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Non-animal Type Hard Capsules Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Non-animal Type Hard Capsules Sales by Application (2018-2024) & (K Units)
Table 87. Asia Non-animal Type Hard Capsules Sales by Application (2024-2029) & (K Units)
Table 88. Asia Non-animal Type Hard Capsules Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Non-animal Type Hard Capsules Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Non-animal Type Hard Capsules Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Non-animal Type Hard Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Non-animal Type Hard Capsules Sales by Region (2018-2024) & (K Units)
Table 94. Asia Non-animal Type Hard Capsules Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 108. Lonza Company Information
Table 109. Lonza Description and Major Businesses
Table 110. Lonza Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Lonza Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Lonza Recent Developments
Table 113. Catalent Company Information
Table 114. Catalent Description and Major Businesses
Table 115. Catalent Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Catalent Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Catalent Recent Developments
Table 118. ACG Associated Capsules Company Information
Table 119. ACG Associated Capsules Description and Major Businesses
Table 120. ACG Associated Capsules Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. ACG Associated Capsules Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. ACG Associated Capsules Recent Developments
Table 123. Qualicaps (Mitsubishi Chemical) Company Information
Table 124. Qualicaps (Mitsubishi Chemical) Description and Major Businesses
Table 125. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Qualicaps (Mitsubishi Chemical) Recent Developments
Table 128. Bahrain Pharma Company Information
Table 129. Bahrain Pharma Description and Major Businesses
Table 130. Bahrain Pharma Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Bahrain Pharma Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Bahrain Pharma Recent Developments
Table 133. JC Biological Technology Company Information
Table 134. JC Biological Technology Description and Major Businesses
Table 135. JC Biological Technology Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. JC Biological Technology Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. JC Biological Technology Recent Developments
Table 138. CapsCanada Company Information
Table 139. CapsCanada Description and Major Businesses
Table 140. CapsCanada Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. CapsCanada Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. CapsCanada Recent Developments
Table 143. Medicaps Company Information
Table 144. Medicaps Description and Major Businesses
Table 145. Medicaps Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Medicaps Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Medicaps Recent Developments
Table 148. Aenova Company Information
Table 149. Aenova Description and Major Businesses
Table 150. Aenova Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Aenova Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Aenova Recent Developments
Table 153. Patheon (Banner Pharmacaps) Company Information
Table 154. Patheon (Banner Pharmacaps) Description and Major Businesses
Table 155. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Patheon (Banner Pharmacaps) Recent Developments
Table 158. Roxlor Company Information
Table 159. Roxlor Description and Major Businesses
Table 160. Roxlor Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Roxlor Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Roxlor Recent Developments
Table 163. Sunil Healthcare Company Information
Table 164. Sunil Healthcare Description and Major Businesses
Table 165. Sunil Healthcare Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Sunil Healthcare Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Sunil Healthcare Recent Developments
Table 168. Arab-Caps Company Information
Table 169. Arab-Caps Description and Major Businesses
Table 170. Arab-Caps Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Arab-Caps Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Arab-Caps Recent Developments
Table 173. Jedco International Pharmaceutical Company Information
Table 174. Jedco International Pharmaceutical Description and Major Businesses
Table 175. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Jedco International Pharmaceutical Recent Developments
Table 178. Pharco Company Information
Table 179. Pharco Description and Major Businesses
Table 180. Pharco Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Pharco Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Pharco Recent Developments
Table 183. ACPL Company Information
Table 184. ACPL Description and Major Businesses
Table 185. ACPL Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. ACPL Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. ACPL Recent Developments
Table 188. Hunan Er-Kang Pharmaceutical Co., Ltd Company Information
Table 189. Hunan Er-Kang Pharmaceutical Co., Ltd Description and Major Businesses
Table 190. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments
Table 193. Procaps S.A Company Information
Table 194. Procaps S.A Description and Major Businesses
Table 195. Procaps S.A Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. Procaps S.A Non-animal Type Hard Capsules Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Procaps S.A Recent Developments
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Non-animal Type Hard Capsules Distributors List
Table 201. Non-animal Type Hard Capsules Customers List
Table 202. Non-animal Type Hard Capsules Market Trends
Table 203. Non-animal Type Hard Capsules Market Drivers
Table 204. Non-animal Type Hard Capsules Market Challenges
Table 205. Non-animal Type Hard Capsules Market Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-animal Type Hard Capsules Product Picture
Figure 2. Global Non-animal Type Hard Capsules Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Non-animal Type Hard Capsules Market Share by Type in 2022 & 2029
Figure 4. Type I Product Picture
Figure 5. 00E Product Picture
Figure 6. 0E Product Picture
Figure 7. Global Non-animal Type Hard Capsules Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Non-animal Type Hard Capsules Market Share by Application in 2022 & 2029
Figure 9. Pharmaceutical
Figure 10. Nutraceutical
Figure 11. Cosmetics
Figure 12. Non-animal Type Hard Capsules Report Years Considered
Figure 13. Global Non-animal Type Hard Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Non-animal Type Hard Capsules Revenue 2018-2029 (US$ Million)
Figure 15. Global Non-animal Type Hard Capsules Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2029)
Figure 17. Global Non-animal Type Hard Capsules Sales 2018-2029 ((K Units)
Figure 18. Global Non-animal Type Hard Capsules Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Non-animal Type Hard Capsules Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Non-animal Type Hard Capsules Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Non-animal Type Hard Capsules Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Non-animal Type Hard Capsules Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Non-animal Type Hard Capsules Sales YoY (2018-2029) & (K Units)
Figure 24. China Non-animal Type Hard Capsules Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Non-animal Type Hard Capsules Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Non-animal Type Hard Capsules Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Non-animal Type Hard Capsules Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Non-animal Type Hard Capsules in the World: Market Share by Non-animal Type Hard Capsules Revenue in 2022
Figure 31. Global Non-animal Type Hard Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
Figure 33. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
Figure 34. Global Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
Figure 35. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Non-animal Type Hard Capsules Revenue Share by Country (2018-2029)
Figure 41. US & Canada Non-animal Type Hard Capsules Sales Share by Country (2018-2029)
Figure 42. U.S. Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
Figure 45. Europe Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
Figure 46. Europe Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
Figure 47. Europe Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
Figure 48. Europe Non-animal Type Hard Capsules Revenue Share by Country (2018-2029)
Figure 49. Europe Non-animal Type Hard Capsules Sales Share by Country (2018-2029)
Figure 50. Germany Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 51. France Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 55. China Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
Figure 56. China Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
Figure 57. China Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
Figure 58. China Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
Figure 59. Asia Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
Figure 60. Asia Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
Figure 61. Asia Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
Figure 62. Asia Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
Figure 63. Asia Non-animal Type Hard Capsules Revenue Share by Region (2018-2029)
Figure 64. Asia Non-animal Type Hard Capsules Sales Share by Region (2018-2029)
Figure 65. Japan Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 69. India Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Non-animal Type Hard Capsules Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Non-animal Type Hard Capsules Sales Share by Country (2018-2029)
Figure 76. Brazil Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Non-animal Type Hard Capsules Revenue (2018-2029) & (US$ Million)
Figure 81. Non-animal Type Hard Capsules Value Chain
Figure 82. Non-animal Type Hard Capsules Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed